TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2016

SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay.

Primo N Lara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.